Dr. Pasternak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
179 Duane St. #5
New York, NY 10013Phone+1 732-594-3496
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1979
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1977 - 1978
- Massachusetts General HospitalResidency, Internal Medicine, 1974 - 1977
- Yale School of MedicineClass of 1974
Certifications & Licensure
- CA State Medical License 1979 - 2026
- MA State Medical License 1976 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 14 citationsCarotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients A Pooled Analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE StudiesMenno Vergeer, Rong Zhou, Michiel L. Bots, Raphaël Duivenvoorden, Joerg Koglin
Circulation. Cardiovascular Imaging. 2010-07-01 - Letter by Pasternak and Cahill Regarding Article, “Manuscript Preparation and Publication”Richard C. Pasternak, Matthew Cahill
Circulation. 2010-06-08 - 67 citationsAn update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) designRobert M. Califf, Yuliya Lokhnygina, Christopher P. Cannon, Michael Stepanavage, Carolyn H. McCabe
American Heart Journal. 2010-05-01
Press Mentions
- A New Cholesterol Study Puts Focus on Merck DrugsNovember 12th, 2009
- A New Cholesterol Study Puts Focus on Merck DrugsNovember 12th, 2009
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: